Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ecoguided Genicular Nerve Block in Knee Osteoarthritis
NCT06619080Completed
- Sponsor
- Hospital Universitario Fundación Alcorcón
- Start
- Apr 2023
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of bupivacaine in osteoarthritis (OA), sponsored by Hospital Universitario Fundación Alcorcón. Primary endpoint: Reduction in Pain at 24 weeks. Started Apr 2023; status: completed.
02
Drugs
bupivacaine
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06619080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06619080.